Neither Interleukin-6 nor Inducible Nitric Oxide Synthase Is Required for Clearance of Chlamydia trachomatis from the Murine Genital Tract Epithelium
暂无分享,去创建一个
[1] K. Murphy,et al. T cell genetic background determines maintenance of IL-12 signaling: effects on BALB/c and B10.D2 T helper cell type 1 phenotype development. , 1997, Journal of immunology.
[2] G. Byrne,et al. Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice , 1997, Infection and immunity.
[3] H. Caldwell,et al. Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice , 1997, Infection and immunity.
[4] A. Sher,et al. Defects in cell-mediated immunity affect chronic, but not innate, resistance of mice to Mycobacterium avium infection. , 1997, Journal of immunology.
[5] A. Sher,et al. Inducible Nitric Oxide Is Essential for Host Control of Persistent but Not Acute Infection with the Intracellular Pathogen Toxoplasma gondii , 1997, The Journal of experimental medicine.
[6] H. Caldwell,et al. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways. , 1997, Journal of immunology.
[7] R. Zinkernagel,et al. Crucial Role of Interferon Consensus Sequence Binding Protein, but neither of Interferon Regulatory Factor 1 nor of Nitric Oxide Synthesis for Protection Against Murine Listeriosis , 1997, The Journal of experimental medicine.
[8] E. Furth,et al. Liver Failure and Defective Hepatocyte Regeneration in Interleukin-6-Deficient Mice , 1996, Science.
[9] E. Peterson,et al. Role of neutrophils in controlling early stages of a Chlamydia trachomatis infection , 1996, Infection and immunity.
[10] W. F. Campbell,et al. Nitric oxide production: a mechanism of Chlamydia trachomatis inhibition in interferon-γ-treated RAW264.7 cells , 1996 .
[11] M. Kopf,et al. IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection. , 1996, Journal of immunology.
[12] R. Rank,et al. Integrin‐mediated epithelial‐T cell interaction enhances nitric oxide production and increased intracellular inhibition of Chlamydia , 1996, Journal of leukocyte biology.
[13] S. Barber,et al. Differential dysregulation of nitric oxide production in macrophages with targeted disruptions in IFN regulatory factor-1 and -2 genes. , 1996, Journal of immunology.
[14] J. Igietseme,et al. Molecular mechanism of T‐cell control of Chlamydia in mice: role of nitric oxide in vivo , 1996, Immunology.
[15] J. Cobb,et al. Nitric oxide and septic shock. , 1996, JAMA.
[16] F. Miedema,et al. IL-12-induced IL-10 production by human T cells as a negative feedback for IL-12-induced immune responses. , 1996, Journal of immunology.
[17] D. Radzioch,et al. In vivo regulation of nitric oxide production by tumor necrosis factor alpha and gamma interferon, but not by interleukin-4, during blood stage malaria in mice , 1996, Infection and immunity.
[18] V. Poli,et al. Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice , 1996, The Journal of experimental medicine.
[19] W. F. Campbell,et al. Nitric oxide production: a mechanism of Chlamydia trachomatis inhibition in interferon-gamma-treated RAW264.7 cells. , 1996, FEMS immunology and medical microbiology.
[20] J. Igietseme. The molecular mechanism of T-cell control of Chlamydia in mice: role of nitric oxide. , 1996, Immunology.
[21] R. Morrison,et al. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection , 1995, Infection and immunity.
[22] D. Levy,et al. Activation of the signal transducer and transcription (STAT) signaling pathway in a primary T cell response. Critical role for IL-6. , 1995, Journal of immunology.
[23] O. Smithies,et al. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[24] H. Caldwell,et al. CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract , 1995, Infection and immunity.
[25] P. Debré,et al. The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc epsilon RII/CD23 surface antigen. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[26] S. Dalrymple,et al. Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia , 1995, Infection and immunity.
[27] C. Nathan,et al. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase , 1995, Cell.
[28] R. Rank,et al. Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis , 1995, Infection and immunity.
[29] K. Tanaka,et al. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis , 1995, Infection and immunity.
[30] M. Lotz,et al. Interleukin-6: a comprehensive review. , 1995, Cancer treatment and research.
[31] A. Bernad,et al. Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system. , 1994, Immunity.
[32] I. Schneider,et al. Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon gamma and CD8+ T cells , 1994, The Journal of experimental medicine.
[33] A. Husband,et al. The role of interleukin-6 in mucosal IgA antibody responses in vivo. , 1994, Science.
[34] M. Washington,et al. Nitric oxide produced during murine listeriosis is protective , 1994, Infection and immunity.
[35] E. Unanue,et al. Release of nitric oxide during the T cell-independent pathway of macrophage activation. Its role in resistance to Listeria monocytogenes. , 1993, Journal of immunology.
[36] H. Hatanaka,et al. Interleukin-6 as a neurotrophic factor for promoting the survival of cultured catecholaminergic neurons in a chemically defined medium from fetal and postnatal rat midbrains , 1992, Neuroscience Research.
[37] P. Morrissey,et al. Growth inhibition of Francisella tularensis live vaccine strain by IFN-gamma-activated macrophages is mediated by reactive nitrogen intermediates derived from L-arginine metabolism. , 1992, Journal of immunology.
[38] H. Kolb,et al. Nitric oxide: a pathogenetic factor in autoimmunity. , 1992, Immunology today.
[39] J. Gauldie,et al. IL6 and the acute phase reaction. , 1992, Research in immunology.
[40] S. Moncada,et al. Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine. , 1990, Journal of immunology.
[41] J. Hibbs,et al. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. , 1990, Journal of immunology.
[42] S. James,et al. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. , 1989, Journal of immunology.
[43] J. Schachter. Pathogenesis of chlamydial infections. , 1989, Pathology and immunopathology research.
[44] C. Nathan,et al. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. , 1988, Journal of immunology.